Background: The fi rst case of pandemic Infl uenza A (
Introduction
Infl uenza is caused by a highly infectious respiratory virus with a potential to rapidly spread in susceptible host. 1 In April 2009, a novel strain of Infl uenza A (H1N1) virus, which is antigenically and genetically unrelated to human seasonal infl uenza virus was identifi ed in Mexico. [2] [3] [4] Compared with previous pandemics of this century, Infl uenza A (H1N1) has high transmission ability but low virulence. 5 However, it can cause severe complications such as pneumonia resulting in respiratory failure, acute respiratory distress syndrome, multi-organ failure and death. 1 In late April 2009, the World Health Organization (WHO) declared the emergence of this virus as a "public health emergency of international concern" and on June 2009, raised the phase of pandemic alert to six, indicating the beginning of the new pandemic. 6 As of 27 th December 2009, worldwide more than 208 countries and overseas territories or communities had reported laboratory confi rmed cases of infl uenza A (H1N1), including 12,220 deaths. 7 In WHO Southeast Asia region 41,513 cases of A (H1N1) virus and 573 deaths were reported as of October 2009. The case fatality rates in the USA and United Kingdom (UK) was in the range of 0.1-0.2%.
The fi rst confi rmed case of A (H1N1) in India was reported on 16 th May, 2009. The patient was a passenger who travelled from USA to Hyderabad. 9 Thereafter, community transmission was reported from many parts of the country. 10 As per the national guidelines, pharyngeal or nasopharyngeal swabs were collected from the suspected case-patients and their close contacts for detection of the virus using real-time-polymerase chain reaction (RT-PCR) assay. 11 Only laboratory confi rmed cases were provided with the antiviral treatment. 12, 13 The Andhra Pradesh State health department identifi ed treatment centers (nodal sites) across the State for isolation and management of suspected/confi rmed pandemic infl uenza patients. A screening facility with thermal scanners was installed at the Hyderabad international airport to screen the inbound passengers fl ying into the country. In this paper, we describe the descriptive epidemiology of A (H1N1) cases reported in Andhra Pradesh during May 2009 to December 2010.
Materials and Methods

Study setting and design
Andhra Pradesh (n = 76,210,007) is one of the south Indian states. 14 We reviewed the surveillance data on influenza A (H1N1) cases, which occurred during 
Case defi nitions
A suspected case of influenza like illness (ILI) was defi ned as the occurrence of acute febrile respiratory illness (fever ≥38°C) with the onset within seven days of close contact with a person who is a confi rmed case of pandemic infl uenza A (H1N1) virus infection or within seven days of travel to areas where there are one or more confi rmed pandemic infl uenza A (H1N1) cases, or resides in a community where there are one or more confi rmed pandemic infl uenza cases. A suspected case of ILI with laboratory confi rmed infl uenza A (H1N1) virus infection in an accredited laboratory through RT-PCR 11 was considered to be laboratory confi rmed case. Death due to A (H1N1) was considered when the infection was confi rmed by laboratory testing, either before or after death. All the casepatients who were residents of Andhra Pradesh reported to IDSP from all districts of Andhra Pradesh, between May 2009 and December 2010 were included in the analysis.
Data source, collection and analysis
Active and stimulated passive surveillance was set up through IDSP across all the districts in the state. Cases and deaths of A (H1N1) were notifi ed to state surveillance unit using structured data collection tool developed by Ministry of Health and Family Welfare. Pharyngeal or nasopharyngeal swab samples of suspected case-patients were sent to Institute of Preventive Medicine (IPM) from all treatment sites across the state. The samples were processed and analyzed using RT-PCR assay in accordance with the National protocol. 15 The surveillance data available at the state IDSP cell (abstract line list of all cases and individual death reports) and IPM (line list of all samples received) was collected, collated and reviewed. Death reports had information on demographics, results of laboratory tests for A (H1N1), cause of death, time course of illness (date of symptom onset, hospital admission, start of antiviral drugs), and underlying medical conditions. Only the death reports from July 2010 had complete details of underlying risk factors, on set and severity symptoms and treatment history, hence records pertaining to January-December 2010 were considered for analysis. We analyzed the data using EPI-Info (Version 3.5.3) software to calculate attack rates, case fatality ratio, distribution of cases and deaths by month of occurrence and frequency of presenting symptoms and known risk factors among A (H1N1) deaths.
Results
Descriptive epidemiology of A (H1N1) cases
During May 2009 to December 2010, a total of 6,527 (Attack rate: 8.6/100,000) suspected cases of A (H1N1) were reported. Of these, 1,480 (23%) samples were positive for A (H1N1) with an attack rate of 1.9/100,000 [ Table 1 ].
The attack rate was higher among males (3/100,000) and those aged 25-49 years (2.6/100,000) [ Table 1 ]. The number of reported cases peaked during AugustOctober in both the years [ Figure 1 ]. 90% of the suspected and 93% of the confi rmed cases were reported from nine districts of Telangana region and 65% of the total confi rmed cases were reported from Hyderabad district of Telangana region [ Figure 2 ].
Descriptive epidemiology of deaths due to A (H1N1)
A total of 109 laboratories confi rmed infl uenza case patients died with a case fatality ratio of 1.7% among all the infl uenza case-patients reported and 7.4% among laboratory confi rmed case-patients. About 3% of the patients who died were older than 60 years of age (Case fatality ratio: 16%). Of the total reported deaths, 73% were reported from nine districts of Telangana.
Of the total deaths that occurred during 2009 and 2010, data about clinical details was available only for 45 deaths that were reported during January 2010 and December 2010. Common symptoms among these case-patients included breathlessness (80%), high fever (58%), headache (38%), chest pain (22%), rhinorrhea (20%), sore throat (18%), vomiting (18%), sputum with blood (16%), diarrhea (7%) at the time of admission [ Table 2 ]. Nearly 80% of the cases who died had a history of comorbid conditions such as chronic obstructive pulmonary disease (COPD) (21%), diabetes (24%), hypertension (12%) and pregnancy (12%), coronary heart disease (8%), Human immunodefi ciency virus (2%), steroid therapy (4%). The median time taken for transportation of the sample to the lab was one day and the mean duration of admission was 5 days. Treatment with Ostealmavir was initiated in 36 cases (80%) and 41 (91%) were put on ventilators. About 20% of patients died on the same day of admission (within 12 h); hence, the treatment was not given. Nearly 80% of the 45 case-patients who died had a history of comorbid conditions. 2009 was incomplete. This phenomenon of incomplete reporting of mortality associated with H1N1 pandemic was observed world-wide. 23 Breathlessness and fever were the most common presenting symptoms among the reported deaths during initial hospitalization. Consistent with studies from India and other countries, fever was the most common symptom that patients with H1N1 have presented. 19, 20, [24] [25] [26] History of chronic illness was reported in 80% of the deaths at the time of admission. Diabetes was the most common comorbid condition with which the patient presented, which was similar to other studies. 1, 5 India being diabetes capital, H1N1 patients presenting with Diabetes remain at higher risk and hence need to be monitored carefully. 27 In a cohort study, among 1479 laboratory-confi rmed and hospitalized cases of pandemic A (H1N1) infl uenza in Canada, risk of severe outcome was found to be highest among patients with diabetes. 27 Similar fi ndings were also reported by other investigators.
28,29
Limitations
Our study had certain limitations. First, we included laboratory-confi rmed patients reporting to the state IDSP unit in the descriptive study. The designated laboratory is present in Hyderabad district of the Telangana region there may be under-reporting from other districts due to non-availability of laboratory facilities. Second, the line-list maintained at the district IDSP units did not have information about case categorization, as well as details of co-morbid conditions, including their BMI. Third the attack rates reported in this study could be an underestimate of the true population rate. The cases reported were mainly from the case-patients attending public sector hospitals. About 84% of the case patients in our study are from the public sector. Deaths that were reported during the second peak (2010) of the pandemic were only analyzed; hence, the estimates derived may either be an over or an underestimate compared with deaths in 2009.
Conclusions
In Andhra Pradesh, the transmission of infl uenza A (H1N1) peaked during August-October months and affected individuals of all age groups with higher attack rates in those aged 25-49 and 0-4 years. Most of the cases were from Telangana (Ranga Reddy) region. The case fatality was higher in the elderly (>65 years) individuals. A history of chronic comorbid condition and presentation with pneumonia lead to poor outcomes and death.
Discussion
The number of reported cases showed peaks during August-October. The attack rate was higher in the age group of 25-49 years. Case fatality rate was higher among patients who were older than 60 years of age compared with other age groups. Most of the patients who died had comorbid conditions.
The number of cases of pandemic influenza A (H1N1) infection in Andhra peaked during August to October in 2009 and 2010. Transmission of infection in various parts of India started around mid-June as in Andhra Pradesh. 16 In Eastern India, the transmission was highest in months of June-July in 2010 10 whereas, the transmission had just started in June 2010 in Andhra Pradesh.
The nine districts of Telangana region of the state accounted for the majority of the suspected (90%) and confi rmed (93%) cases in the State. Hyderabad accounted for 65% of the total cases in the Telangana region. Large number of reported cases in Hyderabad is possibly due to the presence of International Airport where active surveillance was instituted, presence of designated laboratory and the highest number of tertiary hospitals in the state.
Attack rate of A (H1N1) was estimated at 1.9/100,000 population with male preponderance. Similar to the initial case reports of A (H1N1) observed in 2009 across other parts of India, infection was observed in all the age groups suggesting that the population does not have immunity to this virus. 1 Attack rate was highest in the age group of 25-49 years (2.6%) and lowest among >65 years (0.6%) age group as observed in USA, Canada and UK. 15, [17] [18] [19] [20] Higher attack rates in adults observed in Andhra Pradesh was consistent with other studies reported from India. Study by Shlomai et al. from Israel showed that age <65 years was an independent predictor for pandemic (H1N1) 2009 infection. 21 Case fatality was estimated at 7/100 in Andhra Pradesh, which was equal in both the sex. Case fatality reported from India was estimated as 6%. 17 CFR was highest among the age group >65 years, which is similar to other studies documented across the globe. 1, 5, 16, 22 A total of 45 deaths (41%) occurred in 2010 of the total deaths during the pandemic. Death reporting in
